Guinea pig, hyperimmune 512 512 'CMV strain AD169 was used to produce the standard CF antigen. Dense bodies were derived from AD 169-infected human embryonic tonsil fibroblasts.
later yielded CMV, while both throat and urine specimens were CMV-positive at 11 weeks followup. Her serum antibody titers against the standard CMV CF antigen were > 1:512, > 1:512, and 1:256, whereas the corresponding titers against the dense body antigen were < 1:4, 1:8, and 1:16.
Finally, a guinea pig hyperimmune serum which we prepared against middle band material, i.e., the density gradient fraction largely containing enveloped virions, had a CMV CF titer of 1:512 against both the standard antigen and a CF antigen consisting of dense bodies derived from CMV-infected human fibroblasts.
Thus, it seems clear that human sera do have antibodies which react with "purified" dense bodies and that diagnostically significant antibody rises can be picked up using them as the CF antigen, even in the face of persistently high titers against the standard CMV CF antigen. In closing, I would like to suggest that dense bodies not be overlooked as a potentially rich source of immunogenic material for use as a possible vaccine.
